Position in GILD
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$2,926
New position
Shares Held
21
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Silicon Valley Capital Partners holds $14,966,250 across 12 Drug Manufacturers - General names. GILD ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,009 | $11,965,287 | |
| 2 | JNJ |
Johnson & Johnson
|
9,659 | $2,361,045 | |
| 3 | PFE |
Pfizer Inc
|
7,397 | $207,707 | |
| 4 | AMGN |
Amgen Inc
|
487 | $171,350 | |
| 5 | ABBV |
AbbVie Inc.
|
580 | $126,144 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,154 | $69,990 | |
| 7 | MRK |
Merck & Co., Inc.
|
380 | $45,710 | |
| 8 | NVO |
Novo Nordisk A S
|
276 | $10,143 |
All Filings in GILD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,926 | 21 | Shares | Sole | 2026-05-19 | |
| No filing history on record for this holder in this stock. | ||||||